TerminatedNot Applicable

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Epilepsy

Stopped: Lack of recruitement and finalisation of research on this topic by investigator

Belgium4 participantsStarted 2015-02-03

Plain-language summary

The purpose of this study is to assess the effects of repetitive transcranial magnetic stimulation (rTMS) as a treatment for Epilepsia Partialis Continua (EPC) or refractory Status Epilepticus (SE), when standard clinical treatments have failed.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Epilepsia partialis continua or refractory status epilepticus * Prior investigations (EEG, MRI...) show a well-defined neocortical epileptogenic focus * Informed consent signed by the patient or his/her legal representative Exclusion Criteria: * Pregnancy, short-term birth wish or childbearing age without adequate birth control * Intracranial metal hardware (excluding dental filling): surgical clips, shrapnell, electrodes under the stimulation area * Presence of pacemaker, implantable cardioverter-defibrillator (ICD), permanent medication pumps, cochlear implants or deep brain stimulation (DBS)

What they're measuring

Seizure diary

Timeframe: Throughout the study, lasting approximately 4 weeks

Electrographic epileptiform activity

Timeframe: Throughout the study, lasting approximately 4 weeks, with assessment before treatment (if possible) and after treatment

Neurological examination

Timeframe: Throughout the study, lasting approximately 4 weeks

Trial details

NCT IDNCT02560597

SponsorUniversity Hospital, Ghent

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-03

View on ClinicalTrials.gov More Epilepsia Partialis Continua trials